The Opportunity:

Reporting to the Senior Director, Portfolio & Development Finance, as the Director, Clinical Finance, you will be presented with an exciting opportunity to lead a strategically critical finance function in an area of significant importance to the business. You will be the Lead Finance Business Partner and recognized subject matter expert for the Clinical Operations group as well as driving enterprise-wide Finance Business Partnering across CSL’s Global R&D organization.

You will:

• Build strong relationships with the Head of Clinical Operations and their Extended Leadership Team to influence business strategy, investment prioritization, and financial outcomes.
• Own and lead financial narratives, translating complex clinical and financial data into actionable insights and strategic recommendations for senior and executive leadership
• Lead the design, implementation, and optimization of Clinical financial processes, ensuring alignment with enterprise financial strategy and governance expectations.
• Lead a team of Finance Business Partners in support for Clinical Operations while building organizational capability and driving high performance across the function.
• Establish and leverage a deep understanding of the overall Portfolio Development and TA Strategies to shape financial planning, investment decisions, and long-term portfolio value creation.
• Provide strategic financial leadership, recommendations, and decision support to drive short- and long-term portfolio, TA and study goals.

This is a hybrid role, which offers a combination of an onsite and remote work schedule. #LI-hybrid

The Role:

The role holder will be focused on the Clinical Operations group within the Portfolio Development function and play a key role in the delivery of the R&D Finance Business Partner model through effective team deployment. Core activities will include:

Financial Planning and Performance Management

• Lead enterprise financial planning and forecasting activities, identifying risks and opportunities that directly impact R&D portfolio performance and strategic objectives.
• Own, design, and continuously improve financial planning, reporting, and goverance frameworks, including explanation of costings for governance and financial processes.
• Lead the financial planning and reporting requirements for Clinical with accountability for delivering accurate, decision-ready financial outputs aligned to enterprise priorities.
• Drive and influence monthly and quarterly financial reviews, shaping strategic dialogue on business performance, risks, and forward-looking scenarios.
• Integrate complex financial and business data across functions to provide strategic insights that inform executive decision-making.

Value and Insights

• Lead the development of advanced, dynamic financial models to support strategic investment decisions and portfolio optimization.
• Ensure alignment of project budgets and timelines and proactively identify and address variances, recommending strategic actions to mitigate risk and improve outcomes in line with R&D decision frameworks.

Other Accountabilities:

• Champion and embed a strategic Business Partnering model across R&D, elevating finance as a driver of business value and strategic decision making.
• Lead financial evaluation and strategic analysis for external collaborations, partnership,s and acquisitions including due diligence and valuation insights.
• Drive transformation of finance processes and capabilities to enhance organizational performance and decision-making effectiveness.
• Enable executive decision-making by delivering >

  About CSL Behring

  CSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients’ needs by using the latest technologies, we discover, develop and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. We use three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which products can address unmet medical needs and help patients lead full lives.

  
  CSL Behring operates one of the world’s largest plasma collection networks, CSL Plasma. Our parent company, CSL, headquartered in Melbourne, Australia, employs 32,000 people, and delivers its lifesaving therapies to people in more than 100 countries.

  To learn more about CSL, CSL Behring, CSL Seqirus and CSL Vifor visit https://www.csl.com/ and CSL Plasma at https://www.cslplasma.com/.

  Our Benefits

  For more information on CSL benefits visit How CSL Supports Your Well-being | CSL.

  You Belong at CSL

  At CSL, Inclusion and Belonging is at the core of our mission and who we are. It fuels our innovation day in and day out. By celebrating our differences and creating a culture of curiosity and empathy, we are able to better understand and connect with our patients and donors, foster strong relationships with our stakeholders, and sustain a diverse workforce that will move our company and industry into the future.

  To learn more about inclusion and belonging visit https://www.csl.com/careers/inclusion-and-belonging

  Equal Opportunity Employer

  CSL is an Equal Opportunity Employer. If you are an individual with a disability and need a reasonable accommodation for any part of the application process, please visit https://www.csl.com/accessibility-statement.